Skip to main content

A Laboratory Study to Evaluate A Blood Biomarker that can Distinguish between the Presence or Absence of Aggressive Prostate Cancer

A Laboratory Study to Evaluate A Blood Biomarker that can Distinguish between the Presence or Absence of Aggressive Prostate Cancer

Associated Conditions

CancerProstate Cancer

Principal Investigator

Sponsor

Genomic Health

The purpose of this study is to evaluate if biomarkers within the blood men with localized prostate cancer can distinguish between those with indolent cancer, defined as Gleason Grade Groups 1 and 2 and those with more aggressive disease.

This study is currently enrolling.


Interested in participating?

Fill out the information below and we will reach out to you within two business days with more information on qualifications for this trial and how to participate.